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ABSTRACT
To analyze the development of antigen-specific IgE in
infants and its clinical usefulness, the levels of IgE anti-
bodies against egg white (f1) and cows' milk (f2) in 33
sera from cord blood, 118 sera from atopic dermatitis
(AD) infants and 197 sera from non-atopic control
infants were measured by using the CAP radioallergo-
sorbent test (RAST) fluoro enzyme immunoassay (FEIA)
system, which has a detection limit of 0.15 Ua/mL for
f1 and 0.20 Ua/mL for f2. No antigen-specific IgE was
detected in cord blood, whereas in infants younger
than 6 months of age, 38.5% of AD infants and 6.6%
of the non-atopic controls showed IgE against f1
(~ 0.70 Ua/mL) and 14.3 and 4.0%, respectively,
showed low levels (0.15-0.70 Ua/mL) of the IgE.
When the cut-off point for positive versus negative
f1 RAST was set at 0.15 or 0.35 Ua/mL instead of
0.70 Ua/mL, the significance of the difference in
f1 RAST-positive and -negative proportions between
atopic and non-atopic infants did not change.
Repeated examination of f1 RAST revealed later posi-
tive conversion in the majority of AD patients, with no
detectable or very low levels (0.15-0.35 Ua/mL) of
f1-specific IgE. In infants at 6 months of age or older,
44.4 and 12.0% of AD patients and non-atopic
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controls, respectively, showed IgE against f1 (~O. 70
Ua/mL) and 37.1 and 22.6%, respectively, showed low
levels (0.15-0.70 Ua/mL) of the IgE. These results
suggest that f1 RAST at a concentration of 0.15 Ua/mL
or higher has diagnostic value for egg allergy in AD
infants, especially in infants younger than 6 months of
age. The fl RAST should be examined repeatedly in
AD infants with low levels of IgE against fl. Similar
results were obtained for f2-specific IgE, but there was
a significant decrease in the specificity when the cut-off
point was set at 0.20 Ua/mL.
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INTRODUCTION
IgE plays an important role in the development of atopic
diseases, such as allergic rhinitis, bronchial asthma and
atopic dermatitis (AD). Although the role of IgE in AD has
not yet been fully clarified, antigen-specific IgE antibodies
have been detected in a large proportion of infants and
young children with AD. Among antigen-specific IgE, egg
white-specific IgE is the most frequently detected in
infants with AD in Japan and cows' milk-specific IgE is the
next most Irequent.I?
Atopic dermatitis in children usually occurs at a very
early time of life. In a previous study, 47 and 72% of
children with AD developed symptoms within the first
6 and 12 months after birth, respectivelv' However, the
diagnosis of AD is sometimes difficult in the early infan-
tile period because its chronic course has not yet been
established. In this situation, the detection of antigen-
specific IgE in the serum of the infant is helpful,
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although not completely specific in the diagnosis of AD
and determination of the ontiqens." Early detection of
food allergy and elimination of the responsible food
may prevent the later development of other food allergy
and respiratory atopy, although this is still centro-
versiol.v" However, we have often encountered infants
with AD without any positive antigen-specific IgE who
later showed high levels of food-specific IgE, as was
also found in the present study.
An antigen-specific IgE antibody concentration lower
than 0.35 Ua/mL (RAST score 0) determined by the
radioallergosorbent test (RAST) has been considered
negative, whereas a RAST score of 2 or higher has been
considered positive in the general population. However,
considering the facts that AD first appears in the early
infantile period and that the serum IgE level is extremely
low at birth and increases during chtldhood.v'" a RAST
score of 1 is sometimes considered positive in infonts.?
This suggests that antigen-specific IgE at concentrations
lower than 0.35 Ua/mL may also have a diagnostic
value.
To clarify the early development of antigen-specific IgE
and the clinical usefulness of its low levels in AD, we
examined serum antigen-specific IgE in cord blood, in
AD infants and in age-matched, non-atopic controls. We
found that low levels (0.15-0.70 Ua/mL) of IgE against
fl have a diagnostic value in AD infants.
METHODS
Patients
Serum was obtained from AD infants and non-atopic
control infants who visited the Departments of Pediatrics at
Kyoto University Hospital and at 15 affiliated hospitals in
eight prefectures in Japan between February 1995 and
March 1996. The AD group consisted of 118 infants
(74 boys) with a mean (± 1 SD) age of 4 ± 2 months
(range 1-11 months). The non-AD control group con-
sisted of 197 infants (105 boys) with a mean age of 5 ± 4
months (range 0-11 months) who visited the hospitals for
health checkups or had some disease other than AD,
bronchial asthma or any other disease that was consid-
ered to influence IgE production. Subjects were selected
randomly using a computer to match for age (month) and
sex. Sera were kept at -40°C until analysis. Ninety-one
percent of infants with AD were being breast fed (53%
breast fed; 38% mixed feeding with breast milk and cows'
milk) and 9% of these infants had only cows' milk at the
time of examination, although the majority of them had
also had breast milk for various periods before the exami-
nation. There was no significant difference in the mode of
feeding between the AD and non-atopic groups. Cord
serum from 33 normal full-term deliveries was also
obtained. Informed consent was obtained from the
parents or the guardians.
Diagnosis of AD
Atopic dermatitits was defined as a pruritic and chronic or
chronically relapsing dermatitis with typical features and
distribution. 11,12 Because the chronic course of AD (one
of the criteria for diagnosis) had not been established in
many patients during the early infantile period, the diag-
nosis of AD was confirmed by repeated examinations in
almost all patients at the earliest 1 month after blood
sampling. The diagnosis of AD was not made in the case
of a patient with eczema, which disappeared easily within
a few weeks of only keeping the skin clean with or without
topical corticosteroids, antibiotics or anti-fungal reagents
and did not appear again after cessation of the therapy.
Detection of serum antigen-specific IgE
Serum levels of specific IgE antibodies against egg white
(f1), cows' milk (f2), soy bean (f14), and mites (d1) were
determined using the CAP RAST FEIA system (Pharmacia
Upjohn Diagnostics, Tokyo, Japan) 13 according to the
manufacturer's instructions.
STATISTICAL METHODS
Data were analyzed using the repeated X2 test with or
without Bonferroni's correction.
RESULTS
Sensitivity of the CAP RASTsystem
We first examined the sensitivity of the CAP RAST FEIA
system. The lowest detectable concentration of IgE deter-
mined as the 0 standard + 3 SD (n = 6) was 0.04-0.05
Ua/mL when solution buffer was used as the 0 standard
(data not shown). A dilution assay using serum containing
known levels of specific IgE against fl, f2, fl4 or d 1
revealed that this assay system satisfactorily detected
serum IgE against these antigens at concentrations below
0.35 Ua/mL (Fig. 1). Examination for reproducibility in
IgE AGAINST EGG WHITE IN INFANTS 131
the measurement of antigen-specific IgE at very low
concentrations revealed that the CAP RAST system
measured serum IgE at the lowest concentrations of 0.15
Ua/mL for f1 and 0.20 Ua/mL for f2, f14 and d 1 with
intra- and interassay coefficients of variation (CV;
n = 3) of less than 10% (data not shown).
Antigen-specific IgE in sera from cord blood,
infants with AD and non-atopic controls
We examined the serum levels of specific IgE against egg
white (f1), cows' milk (f2), soy bean (f14) and mites (d1) in
sera from cord blood, AD infants and non-atopic controls.
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None of the cord sera examined (n = 33) contained
detectable levels (~0.15 Ua/mL for fl and ~ 0.20
Ua/mL for f2, f14 and d 1) of specific IgE against these
antigens, whereas 59.3 and 36.8% of AD infants showed
detectable levels of specific IgE against fl and f2, respec-
tively (Fig. 2; Table 1). In the present study, there were
only two and one AD infants with detectable IgE against
f14 and d 1, respectively.
When the cut-off point for positive versus negative f1
RAST was set at 0.70 Ua/mL (class 2), the proportion
of positive AD infants and non-atopic controls was
38.5 and 6.6%, respectively, in infants younger than
6 months of age and 44.4 and 12.0%, respectively, in
infants 6 months of age or older. When the cut-off
point of f1 RAST was set at 0.35 Ua/mL (class 1) or at
0.15 Ua/mL, the proportion of f1 RAST-positive AD
infants further increased (Table 1). Although the pro-
portions of non-atopic controls with IgE against f1
(~0.35 or ~ 0.15 Ua/mL) were considerably large,
they were still much smaller than those of AD infants,
particularly in infants younger than 6 months of age.
The correlation between age and fl RAST in infants is
shown in Fig. 3.
IgE against f2 showed similar results (Figs 2,3). When
the cut-off point of f2 RAST was set at 0.70 Ua/mL, the
proportion of positive atopic patients and non-atopic
controls was 18.9 and 6.6%, respectively, in infants
younger than 6 months of age and 33.3 and 5.3%,
respectively, in infants 6 months of age or older. When
the cut-off point of f2 RAST was set at 0.35 Ua/mL, the
proportion of positive atopic patients and non-atopic
controls was 28.9 and 9.0%, respectively, in infants
younger than 6 months of age and 40.7 and 12.9%,
respectively, in infants 6 months of age or older. When
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Table 1. IgE against f1 and f2 in infants
Proportion of infants (%)
Age < 6 months Age ~ 6 months Total
IgE level NOR AD NOR AD NOR AD
(Ua/mL) (n=122) (n=91) (n=75) (n=27) (n=197) (n=118)
~-----
f1 RAST <0.15 89.4 47.2 ] 65.4 18.5 ] 80.2 40.7 ]
** ** **
~ 0.15 10.6 52.8 34.6 81.5 19.8 59.3
<0.35 91.0 57.1 ] 74.7 40.7 ] 84.8 53.4 ]
** ** **
~ 0.35 9.0 42.9 25.3 59.3 15.2 46.6
f2 RAST <0.20 81.2 65.6 ] * 81.3 55.6 ] * 81.2 63.2 ]
**
~ 0.20 18.8 34.4 18.7 44.4 18.8 36.8
<0.35 91.0 71.1 ] 87.1 59.3 ] 89.8 68.4 ]
** ** **
~ 0.35 9.0 28.9 12.9 40.7 10.2 31.6
NOR, non=atopic control infants; AD, infants with atopic dermatitis. *P<O.OS, **P<O.Ol.
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Fig. 3 Egg white- and cows' Q) (b)c;
milk-specific IgE in infants. (a) fl 100
RAST; (b) f2 RAST. Serum levels
of IgE against egg white and
cows' milk in infants with AD 80
(AD) and non-atopic control
infants (NOR) are shown accord-
ing to their ages in months. The 60
figures in the bars are the per-
centages and the number of 40
subjects are shown in paren-
theses at the bottom of each
column. (D), ~ 0.35 Ua/mL; 20
(-), 0.15-0.35 Ua/mL in (a)
and 0.20-0.35 Ua/mL in (b);
(~), <0.15 Ua/mL in (a) and 0 ~-~NOR AD 2 NOR AD 4 NOR AD 6 NOR AD 8 NOR AD 12 Age (months)
<0.20 Ua/mL in (b). (56) (6) (33) (46) (33) (38) (33) (15) (42) (12)
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Fig. 4 Serial changes in serum levels of egg white-specific IgE in infants with atopic dermatitis. Infants were divided into three
groups according to f1 RAST titers at the first examination: (a) <0.15 Ua/mL; (b) 0.15-0.35 Ua/mL; (c) ~ 0.35 Ua/mL.
the cut-off point was changed from 0.35 to 0.20 Ua/mL,
the increase in the proportion of f2 RAST-positive AD
patients (5.2%) was smaller than that in the non-atopic
controls (8.6%), with a decrease in the significant differ-
ence in distribution of f2 RAST-positive and -negative
subjects between atopic and non-atopic infants (Table 1).
Serial change in fl RAST levels in infants
with AD
The f1 RAST was examined repeatedly in 41 AD infants
(Fig. 4). Fourteen of 18 patients (77.8%) at 2-4 months
of age without detectable IgE against fl at the time of first
examination later showed IgE against f1 at a concentra-
tion of 0.35 Ua/mL or higher. Four of five AD infants
(80%) with IgE against f1 in the concentration range
0.15-0.35 Ua/mL showed f1 RAST at a concentration of
0.35 Ua/mL or higher at the time of re-examination. In
contrast, 10 of 18 AD infants (55.6%) with f1 RAST at a
concentration of 0.35 Ua/mL or higher showed
decreased levels of f1 RAST at the time of re-examination
within 1 year.
DISCUSSION
IgE against egg white is the most frequently seen antigen-
specific IgE in Japanese infants with AD.l Although the
role of IgE in the pathogenesis of AD has not yet been fully
elucidated, egg allergy plays a central role in the majority
of Japanese infants with AD.l,2 In more than 80% of AD
infants with IgE against egg white, elimination and load-
ing tests have revealed that egg white is the responsible
allergen (S Ito et al., unpubl. obs., 1993). Therefore, IgE
against egg white is considered to be important in the
detection of allergens in AD infants. 1,5, 14
In the present study we detected no IgE against egg
white, cows' milk, soy bean or mites in sera from cord
blood using a sensitive CAP RAST FEIA system and IgE
against egg white or cows' milk gradually became
detectable during the early infantile period in AD patients
and, much less frequently, in non-atopic infants. This is in
good agreement with earlier reports (reviewed by
Zeiqer"). Thus, the early infantile period is the period in
which antigen-specific IgE antibodies mainly develop in
atopic patients and it is to be expected that low levels of
IgE against egg white have some diagnostic value for egg
allergy in infants, particularly in infants younger than
6 months of age.
Determination of the cut-off point of antigen-specific
IgE is difficult; when the cut-off point is set at a high con-
centration, the sensitivity may decrease even though the
specificity may increase. Conversely, when the cut-off
point is set at a low concentration, the specificity may
decrease even though the sensitivity may increase. In the
present study, the sensitivity increased but the specificity
decreased when the cut-off point for f1 RAST was set at
0.35 or 0.15 Ua/mL instead of 0.75 Ua/mL; consider-
ably large proportions (15.2 and 19.8%, respectively) of
non-atopic control infants, even including those younger
than 6 months of age, were positive for egg white-
specific IgE when the cut-off points were set at 0.35 and
0.15 Ua/mL. As far as the specificity is concerned, this is
a disadvantage of low cut-off points. However, even
when the cut-off point was set at 0.70 Ua/mL, there was
still a considerable proportion (8.6%) of positivity for
fl RAST in non-atopic controls. It is apparent that IgE
RAST cannot completely diagnose allergy by itself and
that the determination of food allergens in children with
AD by serum antigen-specific IgE should be carefully
confirmed, particularly in older children, by elimination
and loading tests, as previously described;" Moreover,
the existence of food-specific IgE does not necessarily
result in AD. Considerably large proportions of control
infants without AD were positive for fl RAST or f2 RAST
even when the cut-off point was set at 0.70 Ua/mL.
Because we did not examine the family history of atopic
diseases in the control group, it is likely that infants with a
family history of atopic disease existed in the control
group. They may have increased the proportion of f1
RAST- and f2 RAST-positive results in control infants.
Unfortunately, we could not follow up these infants in
terms of the later development of AD. It is likely that food-
specific IgE plays an important role in the development of
AD in infants, but that the development of AD in infants
with IgE against food involves other factors.
Although we understand the limited diagnostic speci-
ficity of IgE RAST for the detection of food allergy, we
propose that IgE against egg white at a concentration of
0.15 Ua/mL or higher in infants with AD, particularly
those younger than 6 months of age, has some diag-
nostic value for egg allergy for the following reasons.
First, many AD infants without detectable f1 RAST later
showed high f1 RAST levels. Moreover, although we did
not confirm by elimination and loading tests that egg
allergy was responsible for AD in the AD infants with low
levels of IgE against egg white in the present study, elim-
ination and loading tests in a previous study had shown
that egg allergy was responsible for AD in more than
85% of AD infants with positive f1 RAST (~0.35
Ua/mL), while this was the case in only 70% of AD chil-
dren at 2-3 years of age (S Ito, unpubl. obs., 1993).
Furthermore, AD in children mainly develops within the
first 6 months of life 3 and the early detection of egg
allergy followed by the early elimination of eggs from
the diet may be useful in preventing the later develop-
ment of allergy against other cntiqens." These data
strongly suggest that low levels of IgE against f1 are
useful, although not completely specific, for the early
detection of egg allergy in AD infants. When the cut-off
point was set at either 0.35 or 0.15 Ua/mL, the signifi-
cant difference (P < 0.01) in the distribution of f1
RAST-positive and -negative subjects between atopic
and non-atopic infants did not change. At the very least,
f1 RAST should be examined repeatedly in AD infants
with IgE against egg white at a concentration of ~ 0.15
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Ua/mL. Elimination and loading tests should be under-
taken to further clarify the existence of egg allergy in AD
infants with very low levels (0.15-0.35 Ua/mL) of egg
white-specific IgE.
The proportion of infants with IgE against egg white
increased after 6 months of age, even in non-atopic
control infants. As Japanese infants usually start eating
eggs after 5-6 months of age, the increase in the propor-
tion of infants with IgE against egg white in the non-atopic
control group was likely to be due to the increased egg
intake. Because many infants in the present study who
were fed cows' milk were also fed breast milk and because
we did not examine egg intake by the infants or their
mothers, we could not determine whether there was a cor-
relation between egg white-specific IgE levels and the
levels of egg intake.
Interestingly, the proportion of AD infants with egg
white-specific IgE was smaller in the group of infants
older than 8 months of age compared with those at
6-8 months of age and fl-specific IgE levels decreased
in 56% of AD infants at the time of re-examination within
1 year. It is suggested that the level of egg white-specific
IgE starts decreasing at approximately 8 months of age in
some AD infants. The early decrease of serum egg white-
specific IgE levels in AD children has been noted
previously. 1,16
The examination for IgE against cows' milk showed
similar results to those of IgE against egg white and
f2 RAST at a concentration of ~ 0.35 Ua/mL is consid-
ered to have a diagnostic value for milk allergy in infants.
However, the very low level of IgE against cows' milk
(0.20-0.35 Ua/mL) was seen in non-atopic control
infants more frequently than in AD infants. Therefore, the
very low level of f2 RAST may be helpful for the diagnosis
of milk allergy during the early infantile period, but is less
reliable than fl RAST.
ACKNOWLEDGEMENTS
We thank Drs K Miyanomae and Y Inoue (National South
Kyoto Hospital), T Ishigami (National Kyoto Hospital),
Y Tabata (Yasaka Hospital, Kyoto), K Yamaoka (Hikone
Municipal Hospital), T Hirota (Koga Hospital, Shiga),
S Seto (Kishiwada Municipal Hospital), S-I Sumimoto
(Osaka Red Cross Hospital, Osaka), M Nanbu (Tenri
Yorozusodansho Hospital, Nara), A Yoshida (Japan
Red Cross Wakayama Medical Centre, Wakayama),
H Yoshimura (Amagasaki Hospital), H Akutagawa and
T Hirao (Tsukaguchi Hospital, Hyogo), H Tsuda (Fukui
136 M MAYUMI ET AL.
Prefecture Hospital, Fukui) and H Sasaki (Kurashiki
Central Hospital, Okayama) for collecting blood
samples. We also thank Ms T Tamura (Pharmacia Upjohn
Diagnostics) for statistical analyses. This work was sup-
ported by grants from the Ministry of Health and Welfare
of Japan and the Pollution-related Health Damage
Compensation and Prevention Association.
REFERENCES
Mayumi M, Ito 5, Kim K-M, Katamura K, Ohshima Y. Value
of IgE, soluble CD23 and IL-4 in prediction of later devel-
opment of atopic diseases in children. In: Sasaki 5,
Miyamoto T, Hopkin JM (eds). Recent advances in predic-
tion and prevention of childhood allergy. Osaka: Churchill
Livingstone, 1995; 139-49.
2 Mayumi M, Katamura K, Tamura T et 01. Involvement of
genetic factors in early development of bronchial asthma
in Japanese infants with atopic dermatitis. Results of a
1 year follow-up study.Allergology Int. 1997; 46: 83-9.
3 Mayumi M, Ohshima Y, Katamura K et 01. Allergic march
in children: Atopic dermatitis in Japanese children with
bronchial asthma. Allergology Int. 1996; 45: 145-9.
4 Yates VM, Kerr RE, Frier K, Cobb SJ, MacKie RM. Early
diagnosis of infantile seborrhoeic dermatitis and atopic
dermatitis: Total and specific IgE levels. Br. 1. Dermatol.
1983; 108: 639-45.
5 Ito 5, Mikawa H. Immunological aspects of asthma
(prophylaxis). Acta Paediatr. Jpn. 1990; 32: 192-6.
6 Bishop JM, Hill DJ, Hosking CS. Natural history of cow milk
allergy: Clinical outcome. J. Pediatr. 1990; 116: 862-7.
7 Zeiger RS, Heller 5, Mellon MH et 01. Effect of combined
maternal and infant food-allergen avoidance on develop-
ment of atopy in early infancy: A randomized study.
J. Allergy C1in. Immunol. 1989; 84: 72-89.
8 Arshad SH, Matthews 5, Gant C, Hide DW. Effect of aller-
gen avoidance on development of allergic disorders in
infancy. Lancet 1992; 339: 1493-7.
9 Zeiger RS. Atopy in infancy and early childhood: Natural
history and role of skin testing. J. Allergy C1in. Immunol.
1985; 75: 633-9.
10 Kim K-M, Mayumi M, Mikawa H. IgE, IL-4, and soluble
Fc£RII in the serum of atopic and nonatopic children.
Pediatr. Allergy Immunol. 1992; 3: 11-15.
11 Hanifin JM, Rajka G. Diagnostic features of atopic der-
matitis. Acta Derm. Venereol. 1980; 92: 44-7.
12 Schudel P, Wuthrich B. Klinische Verlaufsbeobachtungen
bei Neurodermitis atopica nach dem Kleinkindesalter. Eine
katamnestische Untersuchung anhand von 121 Fallen.
[Clinical course of atopic neurodermatitis. A catamnestic
study of 121 cases.] Z. Hautkr. 1985; 60: 479-86.
13 Ewan PW, Coote D. Evaluation of capsulated hydrophilic
carrier polymer (the immunoCAP) for measurement of spe-
cific IgE antibodies. Allergy 1990; 45: 22-9.
14 Schur 5, Hyde JS, Wypych JI. Egg-white sensitivity and
atopic eczema. J.AllergyC1in. Immunol. 1974; 54: 174-9.
15 Sampson HA, Albergo R. Comparison of results of skin
tests, RAST, and double-blind, placebo-controlled food
challenges in children with atopic dermatitis. J. Allergy
C1in. Immunol. 1984; 74: 26-33.
16 Dannaeus A, Inganas M. A follow-up study of children with
food allergy. Clinical course in relation to serum IgE- and
IgG-antibody levels to milk, egg, and fish. C1in. Allergy
1981; 11: 533-9.
